Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

E-Z-Cat Dry

(Barium)

Small molecule

BBracco Diagnostics, Inc

0

Indications

2

Total Trials

1

Active Trials

0

Competitors

4

FDA Applications

NDA/BLA/ANDA regulatory filings

Timeline

Expected Milestones

Q1 2027

N/AActive, not recruiting

Head and Neck

NCT02662907

Clinical

Trials by Indication[1]

Oral1 trial

Uniformity of Oral Contrast Material in the Bowel

Completed·UUniversity of California, San Francisco··NCT02542046·900 enrolled

Head and Neck1 trial

Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy

Active, not recruiting·MM.D. Anderson Cancer Center·N/A·NCT02662907·175 enrolled

Regulatory

FDA Approval Timeline[3]

Oct 14, 2016

VARIBAR PUDDING

NDA NDA208844

Jan 3, 2017

E-Z-CAT DRY

NDA NDA208036

May 29, 2020

ENTERO VU 24%

NDA NDA208143

Aug 1, 2025

E-Z-DISK

NDA NDA219840

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Barium. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Barium compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA219840). U.S. Food & Drug Administration.
[4]
SEC EDGAR — Bracco Diagnostics, Inc company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: BBracco Diagnostics, Inc

Related News